Effects of Water and Glucose Drinks on Cardiovascular Function in Subjects With and Without Postprandial Hypotension

Not Applicable

Completed

• Conditions: Blood Pressure; Baroreflex Failure; Autonomic Nervous System Diseases; Hypotension
• Interventions: Other: Glucose; Other: Water

• Registration Number: NCT02713412
• Lead Sponsor: Royal Adelaide Hospital

Brief Summary

To determine whether the changes in blood pressure (BP) which occur following meals in normal people and patients who have substantial falls in BP after a meal postprandial hypotension (PPH)) are associated with changes in cardiac function. Eligible subjects who have been previously diagnosed with PPH will report to the Queen Elizabeth Hospital, on two occasions, following an overnight fast. Subjects will be cannulated and have a BP cuff placed around their upper arm. Following this, subjects will ingest either a drink containing 75 grams of glucose and 150mg of a C13 Acetate (which is metabolised and excreted in the breath, enabling noninvasive measurements of gastric emptying), made up to 300mL water, or on the other study day, 300mL water alone. The order of the study days will be randomised. Following the drink, for 3 hours, measurements will be taken at regular intervals of BP, heart rate, breath samples (on the study day with the Acetate only), blood samples (for measurement of blood glucose and gut hormones) and transthoracic echocardiography (TTE) (for assessment of end systolic and diastolic cardiac volume, cardiac output, cardiac contractility and diastolic function). After the 3 hours of measurements, the cannula will be removed and subjects will be offered lunch prior to leaving the department. Following lunch, on one study day, subjects will have their autonomic nerve function tested noninvasively, using an ECG.

Detailed Description

Subjects who meet the inclusion criteria will be required to attend the Queen Elizabeth Hospital, on two separate occasions, at 08:30h following an overnight fast (solids for 14 hours and liquids for 12 hours) and abstaining from smoking for 12 hours prior to the study day. The order of the study days will be randomized using the online Random Integer Set Generator program (RANDOM.ORG).

On each of the study days, subjects will be seated and have an intravenous cannula inserted into an antecubital vein in the arm for blood sampling and an automated blood pressure (BP) cuff (DINAMAP ProCare 100, GE Medical Systems, Milwaukee, WI, USA) placed around the opposite arm for measurements of BP (systolic and diastolic) and heart rate (HR).

After a 15-minute rest period, subjects will consume a drink consisting of either 75g glucose and 150 mg of 13C-acetate made up to 300 ml with water, or 300 ml water, within 3 minutes (t = -3 - 0 minutes).

BP and HR will be measured at 3 minute intervals during the 30-minute rest period prior to the drink (i.e. t = -30 - 0 minutes) and at 3 minute intervals from t = 0 - 180 minutes.

Blood samples (\~ 18ml) will be taken prior (t = -3 minutes) to the drink and then at t = 30, 60, 90, 120 and 180 minutes for the subsequent measurement of blood glucose, serum insulin and incretin hormones. Samples will be stored at -70°C until analysed. Blood glucose will be determined immediately using a portable glucometer (Medisense Companion 2 meter, Medisense Inc, Waltham, USA).

Following the 75g drink consisting of 75g glucose and 150 mg of 13C-acetate made up to 300 ml with water, at t = -3 minutes, and every 5 minutes between t = 0 - 60, followed by every 15 minutes between t = 60 - 180, breath samples will be collected in sealed tubes for subsequent analysis of 13CO2 for measurement of gastric emptying.

At t = -30 minutes and then at t = 30, 60, 90, 120 and 180 minutes, subjects will also undergo Transthoracic Echocardiogram (TTE) for assessment of (i) end-systolic and diastolic volumes (ii) cardiac output (iii) cardiac contractility, as assessed by measuring

1. left ventricular dP/dt and

2. overall wall motion by Doppler tissue imaging (DTI) of basal mitochondrial segments (iv) diastolic function, as assessed by measuring

a) mitral inflow velocities b) DTI of mitral annulus c) left atrial size and d) pulmonary vein flow patterns Prior to each measurement, subjects will be allowed to rest for 15 minutes, remaining still in a supine position.

At t = 180 the cannulae will be removed and subjects will be offered a light lunch before leaving the department. The total amount of blood collected during the two visits is \~180 ml.

On one of the study days after completion of these measurements autonomic nerve function will be assessed using standardised cardiovascular reflex tests. Parasympathetic function will be calculated by the variation (R - R interval) of the HR during deep breathing and the immediate HR response to standing ("30:15" ratio). Sympathetic function will be assessed by the fall in systolic BP in response to standing.

Study Timeline

• Study Start: 2013-04
• Primary Completion: 2014-10
• Study Completion: 2014-10
• Status Verified: 2016-03
• Study First Submitted: 2016-03-06
• Study First Submitted QC: 2016-03-15
• Last Update Submitted: 2016-03-15
• Study First Posted: 2016-03-18
• Last Update Posted: 2016-03-18

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 8

Inclusion Criteria

• Control subjects: subjects from this group will be healthy, with normal BMI. PPH subjects: Patients who have been diagnosed with PPH (defined as a fall in systolic blood pressure (BP) of > 20mmHg within 2 hours of a meal).

Read More

Exclusion Criteria

• No history of severe respiratory, cardiovascular, hepatic and/or renal disease, diabetes, are not taking any medication with effects on blood pressure or gastrointestinal function, have not donated blood for the past 12 weeks or been involved in any research projects for the past 3 months.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Glucose	Glucose	75g glucose and 150mg C13-acetate in 300ml water
Control	Water	300ml water

Primary Outcome Measures

Name	Time	Method
Change from baseline systolic blood pressure over time.	time= 0 - 120 min	time= 0 min is defined as the consumption of either the experimental or control drink, i.e. outcome will be assessed for 2 hours.

Secondary Outcome Measures

Name	Time	Method
Change from baseline cardiac output as assessed by echocardiography, over time.	time= 0 - 120 min	time= 0 min is defined as the consumption of either the experimental or control drink, i.e. outcome will be assessed for 2 hours.
Change from baseline stroke volume as assessed by echocardiography, over time.	time= 0 - 120 min	time= 0 min is defined as the consumption of either the experimental or control drink, i.e. outcome will be assessed for 2 hours.
Change from baseline ejection fraction as assessed by echocardiography, over time.	time= 0 - 120 min	time= 0 min is defined as the consumption of either the experimental or control drink, i.e. outcome will be assessed for 2 hours.